Iridex (IRIX) Liabilities and Shareholders Equity (2011 - 2026)

Iridex has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $28.3 million in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 17.41% year-over-year to $28.3 million; the trailing twelve-month figure through Apr 2026 stood at $117.4 million (down 5.94% YoY), and the FY2026 full-year result was $29.2 million, changed 0.05% from the prior year.
• Liabilities and Shareholders Equity for Q2 2026 stood at $28.3 million, down from $29.2 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $48.7 million in Q1 2022, with the low at $28.3 million in Q2 2026.
• Average Liabilities and Shareholders Equity over 5 years is $36.3 million, with a median of $34.3 million recorded in 2023.
• Year-over-year, Liabilities and Shareholders Equity soared 74.07% in 2022 and declined 22.26% in 2023.
• Tracing IRIX's Liabilities and Shareholders Equity over 5 years: stood at $42.3 million in 2022, then declined by 18.57% to $34.4 million in 2023, then fell by 15.39% to $29.1 million in 2024, then dropped by 2.68% to $28.4 million in 2025, then decreased by 0.28% to $28.3 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $28.3 million (Q2 2026), $29.2 million (Q1 2026), and $28.4 million (Q3 2025), per Business Quant data.

Peer Comparison